Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
This study provides updated rank-order efficacy of MASH pharmacological therapies for fibrosis regression and MASH resolution. These data are helpful to inform practice and clinical trial design.
Authors
- Daniel Q. Huang (ORCID: https://orcid.org/0000-0002-5165-5061)
- Rohit S. Loomba (ORCID: https://orcid.org/0000-0002-9116-2835)
- Matheus Henrique Gonçalves de Souza (ORCID: https://orcid.org/0009-0005-3695-9701)
- Vânio Antunes (ORCID: https://orcid.org/0009-0007-1127-230X)
- Lubna Al‐Sharif (ORCID: https://orcid.org/0000-0002-2129-4891)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- National University of Singapore (SG)
- An-Najah National University (PS)
- University of California San Diego (US)
- National University Hospital (SG)
Publication Details
- Journal
- Hepatology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1097/hep.0000000000001254
- Citations
- 56
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 75.84